Patient Background and Telemedicine Context
Mr. Hartono was diagnosed with Rapid Molecular Test TB 4 weeks ago and started on Category 1 FDC (Fixed-Dose Combination) anti-tuberculosis therapy (4-FDC: Rifampicin, Isoniazid, Pyrazinamide, Ethambutol) daily, the patient was already know to consume the anti tuberculosis drug because the doctor's suggestion from the first telemedicine. This is his second scheduled tele-monitoring session. |
Map: Tuberculosis Case _1 (1129)
|
||
|
Review your pathway |